In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 195 for your search:
Cancer Type/Condition:  Endometrial cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 03/2007, NCT00719017
2.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GUM-ET/OV, NCT01389986
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000521447; P06.031, CKTO-2006-04, ISRCTN14387080, P06.031-PORTEC-3, 2007-004917-33, CKTO-PORTEC-3, EU-20664, NCT00411138
4.

Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: SARC-GYN1, NCT00162721
6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 2 to 21
Sponsor: NCI
Protocol IDs: SCUSF-0703, MCC-0703, SCUSF 0703, NCT01132547
7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VRAM M-20070240, NCT00647569
8.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 0014-08-RMC, NCT00726635
9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000629591, GOG-0249, NCT00807768
10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TOTEM, NCT00916708
11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and older
Sponsor: NCI, Other
Protocol IDs: CDR0000649079, GOG-0258, NCT00942357
12.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 76
Sponsor: Other
Protocol IDs: PIP2, CSET 1443, NCT00949039
13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373
14.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
15.

Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789
16.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RC08/118, NCT01356329
17.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: IV iron 2, NCT01435200
18.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TACH-01, NCT01470677
19.

Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: PPS-MERT-01, NCT01509313
20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: TOMOGYN - 1105, NCT01641497
21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
22.

Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 60
Sponsor: Other
Protocol IDs: 2011-0739, NCT01697566
23.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AEZS -108-050, NCT01767155
24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: KNC13-005, NCT01805115
25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2012-GYN/EC-01, NCT01820858
1     
New Search